News

How does origami-like DNA affect brain development? How do cancer-immune cell interactions prevent immune cell activity in tumors? Two breakthrough discoveries by UC San Francisco scientists answer these questions and could open new paths to preventing and treating conditions such as autism and

ervical cancer screenings are considered one of the most significant public health advances of the past 50 years, particularly in detecting HPV (human papillomavirus), the culprit of most cervical cancers. This month, the U.S. Department of Health and Human Services updated cervical cancer screening

Johannes R. Kratz, MD, has been named as the inaugural chief of UCSF’s Division of Thoracic Surgery, one of the leading academic robotic thoracic surgery programs in the western U.S. He brings a track record of innovation in surgical oncology and will guide multidisciplinary teams of surgeons

Immune checkpoint inhibitors (ICIs) have revolutionized cancer treatment by using a patient’s own T-cells to target tumors. However, they can cause rare but potentially fatal cardiac inflammation known as ICI-myocarditis. This is particularly true in the most recent ICI combination treatment

Susan Beutler’s story with UCSF starts in 1993 and carries forward to the present day. In 2003, following 10 years of professional acquaintance with the amazing staff of UCSF Health’s Hematology, Blood and Marrow Transplant and Cellular Therapy program, she was privileged to become the patient

A pioneering study has found that an individualized approach to breast cancer screening that assesses patients’ risk, rather than annual mammograms, can lower the chance of more advanced cancers, while still safely match people to the amount of screening they need. The results — which come from 46